93 related articles for article (PubMed ID: 22734206)
1. Screening of substrates of protein arginine methyltransferase 1 in glioma.
Wang S; Tan XC; Yang B; Yin B; Peng XZ
Chin Med Sci J; 2012 Mar; 27(1):1-6. PubMed ID: 22734206
[TBL] [Abstract][Full Text] [Related]
2. Deep Protein Methylation Profiling by Combined Chemical and Immunoaffinity Approaches Reveals Novel PRMT1 Targets.
Hartel NG; Chew B; Qin J; Xu J; Graham NA
Mol Cell Proteomics; 2019 Nov; 18(11):2149-2164. PubMed ID: 31451547
[TBL] [Abstract][Full Text] [Related]
3. The role of protein arginine-methyltransferase 1 in gliomagenesis.
Wang S; Tan X; Yang B; Yin B; Yuan J; Qiang B; Peng X
BMB Rep; 2012 Aug; 45(8):470-5. PubMed ID: 22917032
[TBL] [Abstract][Full Text] [Related]
4. Redox Control of Protein Arginine Methyltransferase 1 (PRMT1) Activity.
Morales Y; Nitzel DV; Price OM; Gui S; Li J; Qu J; Hevel JM
J Biol Chem; 2015 Jun; 290(24):14915-26. PubMed ID: 25911106
[TBL] [Abstract][Full Text] [Related]
5. Protein arginine methylation of SERBP1 by protein arginine methyltransferase 1 affects cytoplasmic/nuclear distribution.
Lee YJ; Hsieh WY; Chen LY; Li C
J Cell Biochem; 2012 Aug; 113(8):2721-8. PubMed ID: 22442049
[TBL] [Abstract][Full Text] [Related]
6. Understanding protein arginine methyltransferase 1 (PRMT1) product specificity from molecular dynamics.
Gathiaka S; Boykin B; Cáceres T; Hevel JM; Acevedo O
Bioorg Med Chem; 2016 Oct; 24(20):4949-4960. PubMed ID: 27545444
[TBL] [Abstract][Full Text] [Related]
7. The arginine methyltransferase PRMT5 and PRMT1 distinctly regulate the degradation of anti-apoptotic protein CFLAR
Li M; An W; Xu L; Lin Y; Su L; Liu X
J Exp Clin Cancer Res; 2019 Feb; 38(1):64. PubMed ID: 30736843
[TBL] [Abstract][Full Text] [Related]
8. Kinetic analysis of human protein arginine N-methyltransferase 2: formation of monomethyl- and asymmetric dimethyl-arginine residues on histone H4.
Lakowski TM; Frankel A
Biochem J; 2009 Jun; 421(2):253-61. PubMed ID: 19405910
[TBL] [Abstract][Full Text] [Related]
9. Proteome-wide Profiling of Asymmetric Dimethylated Arginine in Human Breast Tumors.
Ma M; Liu F; Miles HN; Kim EJ; Fields L; Xu W; Li L
J Am Soc Mass Spectrom; 2023 Aug; 34(8):1692-1700. PubMed ID: 37463068
[TBL] [Abstract][Full Text] [Related]
10. Gestational changes in PRMT1 expression of murine placentas.
Sato A; Kim JD; Mizukami H; Nakashima M; Kako K; Ishida J; Itakura A; Takeda S; Fukamizu A
Placenta; 2018 May; 65():47-54. PubMed ID: 29908641
[TBL] [Abstract][Full Text] [Related]
11. Loss of the major Type I arginine methyltransferase PRMT1 causes substrate scavenging by other PRMTs.
Dhar S; Vemulapalli V; Patananan AN; Huang GL; Di Lorenzo A; Richard S; Comb MJ; Guo A; Clarke SG; Bedford MT
Sci Rep; 2013; 3():1311. PubMed ID: 23419748
[TBL] [Abstract][Full Text] [Related]
12. Increase of arginine dimethylation correlates with the progression and prognosis of ALS.
Ikenaka K; Atsuta N; Maeda Y; Hotta Y; Nakamura R; Kawai K; Yokoi D; Hirakawa A; Taniguchi A; Morita M; Mizoguchi K; Mochizuki H; Kimura K; Katsuno M; Sobue G
Neurology; 2019 Apr; 92(16):e1868-e1877. PubMed ID: 30867270
[TBL] [Abstract][Full Text] [Related]
13. PRMT1 expression is elevated in head and neck cancer and inhibition of protein arginine methylation by adenosine dialdehyde or PRMT1 knockdown downregulates proliferation and migration of oral cancer cells.
Chuang CY; Chang CP; Lee YJ; Lin WL; Chang WW; Wu JS; Cheng YW; Lee H; Li C
Oncol Rep; 2017 Aug; 38(2):1115-1123. PubMed ID: 28656289
[TBL] [Abstract][Full Text] [Related]
14. Quantification of Arginine and Its Methylated Derivatives in Plasma by High-Performance Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS).
Vicente FB; Vespa G; Miller A; Haymond S
Methods Mol Biol; 2016; 1378():21-30. PubMed ID: 26602113
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of PRMT1 gene expression in breast cancer.
Mathioudaki K; Scorilas A; Ardavanis A; Lymberi P; Tsiambas E; Devetzi M; Apostolaki A; Talieri M
Tumour Biol; 2011 Jun; 32(3):575-82. PubMed ID: 21229402
[TBL] [Abstract][Full Text] [Related]
16. Protein arginine methyltransferase I: substrate specificity and role in hnRNP assembly.
Pawlak MR; Banik-Maiti S; Pietenpol JA; Ruley HE
J Cell Biochem; 2002; 87(4):394-407. PubMed ID: 12397599
[TBL] [Abstract][Full Text] [Related]
17. Asymmetric dimethylarginine, an endogenous NOS inhibitor, is actively metabolized in rat erythrocytes.
Yokoro M; Suzuki M; Murota K; Otsuka C; Yamashita H; Takahashi Y; Tsuji H; Kimoto M
Biosci Biotechnol Biochem; 2012; 76(7):1334-42. PubMed ID: 22785485
[TBL] [Abstract][Full Text] [Related]
18. A novel splicing isoform of protein arginine methyltransferase 1 (PRMT1) that lacks the dimerization arm and correlates with cellular malignancy.
Patounas O; Papacharalampous I; Eckerich C; Markopoulos GS; Kolettas E; Fackelmayer FO
J Cell Biochem; 2018 Feb; 119(2):2110-2123. PubMed ID: 28857308
[TBL] [Abstract][Full Text] [Related]
19. PRMT-5 converts monomethylarginines into symmetrical dimethylarginines in Caenorhabditis elegans.
Kanou A; Kako K; Hirota K; Fukamizu A
J Biochem; 2017 Feb; 161(2):231-235. PubMed ID: 28173048
[TBL] [Abstract][Full Text] [Related]
20. Establishment of an ectopically expressed and functional PRMT1 for proteomic analysis of arginine-methylated proteins.
Chang YI; Lin SW; Chiou YY; Sung JS; Cheng LC; Lu YL; Sun KH; Chang K; Lin CH; Lin WJ
Electrophoresis; 2010 Dec; 31(23-24):3834-42. PubMed ID: 21080372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
